Methamphetamine use is associated with several harms, particularly in young adults. There is a lack of effective options to help people manage their methamphetamine use: medications are needed to complement psychosocial treatment and improve outcomes. The MASP study aims to recruit young adults aged 15 to 35-year-olds who use methamphetamine. to allocate them to a trial that best fits their needs (e.g., MASKOT)
MethAmphetamine Use In Young People: Sub-anaesthetic Ketamine Open-label Trial
Funder
NCCRED
Summary
Methamphetamine use is associated with several harms, particularly in young adults. There is a lack of effective options to help people manage their methamphetamine use: medications are needed to complement psychosocial treatment and improve outcomes. The MASKOT study aims to determine the safety and acceptability of ketamine as a treatment for young adults aged 15 to 35-year-olds who use methamphetamine.